A photo of Kavisha Arora.

Instructor, UC Department of Pediatrics

513-803-7628

Biography & Affiliation

Research Interests

Disease-modifying cellular and molecular mechanisms in Cystic Fibrosis and GI-related disorders; airway mucociliary clearance in Cystic Fibrosis

Academic Affiliation

Instructor, UC Department of Pediatrics

Divisions

Pulmonary Medicine

Education

PhD: University of Tennessee Health Science Center, Memphis, TN, 2013.

Publications

IL-13–induced intestinal secretory epithelial cell antigen passages are required for IgE-mediated food-induced anaphylaxis. Noah, TK; Knoop, KA; McDonald, KG; Gustafsson, JK; Waggoner, L; Vanoni, S; Batie, M; Arora, K; Naren, AP; Wang, Y; et al. Journal of Allergy and Clinical Immunology. 2019; 144:1058-1073.e3.

Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis. Zeng, C; Vanoni, S; Wu, D; Caldwell, JM; Wheeler, JC; Arora, K; Noah, TK; Waggoner, L; Besse, JA; Yamani, AN; et al. Journal of Allergy and Clinical Immunology. 2018; 142:1843-1855.

AC6 is the major adenylate cyclase forming a diarrheagenic protein complex with cystic fibrosis transmembrane conductance regulator in cholera. Thomas, A; Ramananda, Y; Mun, K; Naren, AP; Arora, K. The Journal of biological chemistry. 2018; 293:12949-12959.

Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations. Harutyunyan, M; Huang, Y; Mun, K; Yang, F; Arora, K; Naren, AP. American Journal of Physiology: Lung Cellular and Molecular Physiology. 2018; 314:L529-L543.

PP-2, a src-kinase inhibitor, is a potential corrector for F508del-CFTR in cystic fibrosis. Wang, Y; Arora, K; Yang, F; Shin, W; Chen, J; Kihara, D; Naren, AP; Jegga, AG. Cold Spring Harbor Laboratory. 2018.

Guanylate cyclase 2C agonism corrects CFTR mutants. Arora, K; Huang, Y; Mun, K; Yarlagadda, S; Sundaram, N; Kessler, MM; Hannig, G; Kurtz, CB; Silos-Santiago, I; Helmrath, M; et al. JCI insight. 2017; 2.

Epithelial Gpr116 regulates pulmonary alveolar homeostasis via G(q/11) signaling. Brown, K; Filuta, A; Ludwig, M; Seuwen, K; Jaros, J; Vidal, S; Arora, K; Naren, AP; Kandasamy, K; Parthasarathi, K; et al. JCI insight. 2017; 2.

Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function. Arora, K; Naren, AP. Current Drug Targets. 2016; 17:1275-1281.

Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation. Arora, K; Yarlagadda, S; Zhang, W; Moon, C; Bouquet, E; Srinivasan, S; Li, C; Stokes, DC; Naren, AP. American Journal of Physiology: Lung Cellular and Molecular Physiology. 2016; 311:L364-L374.

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration. Sinha, C; Arora, K; Naren, AP. Jove-Journal of Visualized Experiments. 2016; 2016.